Treatment of warts using anthralins and occlusion
AssigneesLeonard Bloom, Marvin S. Townsend
InventorsHoward N. Robinson, Neil F. Martin
Life of this patent
Estimating the term…
Abstract
A method of treating a patient having one or more warts includes the steps of: applying to the wart an amount of a composition consisting essentially of an anthralin active ingredient and a pharmaceutical carrier; covering the wart and skin areas peripheral to the wart with an adhesive tape, such that the adhesive tape adheres to peripheral skin areas, whereby the adhesive tape provides an occluding environment for the wart treated with the composition. The occluding environment is maintained for a desired period of time, and the adhesive tape is removed. For a number of times as desired, a fresh amount of anthralin-containing composition is applied, and a fresh piece of adhesive tape is applied to recreate the occluding environment.
Claims39
A method of treating a patient having one or more warts, said method comprising the steps of:
- (a) applying to a wart an amount of a composition consisting essentially of an anthralin active ingredient in a concentration greater than 0.5% by weight and a pharmaceutical carrier,
- (b) covering the wart and skin area peripheral to the wart with a tape which provides an occluding environment for the wart, and
- (c) maintaining the tape in position over the wart and peripheral skin area for a predetermined period of at least one hour, the tape providing an occluding environment for the wart for the predetermined period of time.
A method of treating a patient having one or more warts, said method comprising the steps of:
- (a) applying to a wart an amount of a composition consisting essentially of an anthralin active ingredient in a concentration ranging from 0.50%-10.0% by weight and a pharmaceutical carrier which includes an oil base for dissolving and suspending the anthralin, an oil-soluble acidifying/stabilizing agent, an aqueous medium, and a water-soluble antioxidant, such that the pharmaceutical carrier and the anthralin are an oil-in-water emulsion,
- (b) covering the wart and skin area peripheral to the wart with an adhesive tape which provides an occluding environment for the wart, and
- (c) maintaining the tape in position over the wart and peripheral skin area for a predetermined period, the tape providing an occluding environment for the wart for the predetermined period of time.
A method of treating a patient having one or more warts, said method comprising the steps of:
- (a) injecting an anthralin-containing composition directly into a wart,
- (b) covering the wart and skin area peripheral to the wart with a tape, and
- (c) maintaining the tape in position over the wart and peripheral skin area for a predetermined period, the tape providing an occluding environment for the wart for the predetermined period of time.
A method of treating a wart comprising the steps of:
- obtaining a composition containing anthralin in a carrier together with a non-therapeutic amount of salicylic acid,
- applying the composition directly on the wart, and
- providing an occluding environment for the wart with a plastic film.
A kit for treating a wart, comprising:
- an occluding means, and
- a quantity of an anthralin composition which includes a carrier containing a non-therapeutic amount of salicylic acid, such that anthralin in the composition is applied directly to the wart, and such that the wart is thereafter covered by said occluding means.
A method of treating a patient having one or more warts, said method comprising the steps of:
- (a) applying to a wart an amount of a composition consisting essentially of an anthralin active ingredient and a pharmaceutical carrier,
- (b) providing an occluding environment for the wart, and
- (c) maintaining the occluding environment for the wart for a period of time of at least one hour.
A method of treating a patient having one or more warts, said method comprising the steps of:
- (a) applying to a wart an amount of a composition consisting essentially of an anthralin active ingredient and a pharmaceutical carrier,
- (b) providing an occluding environment for the wart, and
- (c) maintaining the occluding environment for the wart.
Dependencies are inferred from the claim text.